drugset / Trial / NCT07252414
GenSci143 in Participants With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of GenSci143 in Participants with Advanced Solid Tumors
Timeline
- Start
- 2025-12-20
- Primary completion
- 2028-10-30
- Completion
- 2029-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci143 | Unknown | 0.5 mg/kg | — |
| Subject | GenSci143 | Unknown | 4.5 mg/kg | — |